Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by burritscold on Mar 09, 2016 9:27am

News?

I think there's a good chance we rocket up to 0.11 in the next month or so.
Comment by kizzlmanguy on Mar 09, 2016 9:48am
This is great news! Share dilution is coming and it only means share prices are going up! Big news is on its way, maybe based on FDA or a buyer! Hold on to your shares!
Comment by burritscold on Mar 09, 2016 9:50am
Oops. Or not.
Comment by cheetio on Mar 09, 2016 8:19pm
haaa aaah  ah  uhh  hhaaa  haaaaaaaaaaaaaaaaaaaa
Comment by Biostocks01 on Mar 09, 2016 10:00pm
cheetio ..... haaa aaah  ah  uhh  hhaaa  haaaaaaaaaaaaaaaaaaaa... OSTIE DE MORON......HI HA!!!!! Bio
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities